"Some of that will be incredibly quick, some of it will take years, decades, or even beyond our lifetime," she says."It will recover, but we just don't know what that's going to look like yet."And the...
Stanley Druckenmiller at CNBC's Delivering Alpha on Sept. 28, 2022.Scott Mlyn | CNBCA version of this article first appeared in CNBC's Inside Wealth newsletter...
U.S. President Donald Trump delivers remarks on his administration's healthcare policies, in the Oval Office at the White House in Washington, D.C., U.S., Aug....
The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. The...
Psilocybin mushrooms stand ready for harvest in a humidified "fruiting chamber." John Moore | Getty ImagesThursday's announcement that Eli Lilly will acquire AtaiBeckley, a...
Moderna's expanding pipeline beyond infectious diseases is giving investors a new reason to own the stock after years of uncertainty following the Covid-19 pandemic,...
Eli Lilly and Regeneron are among the first seven companies the U.S. Food and Drug Administration selected for a pilot program designed to accelerate...
Thomas Fuller | SOPA Images | Lightrocket | Getty ImagesUniQure plans to seek FDA approval of its experimental gene therapy for Huntington's disease, the...
